Built with Cells - Immunotherapy

Cellerator and Miltenyi Biotec are pleased to announce Cell Therapy networking series featuring leading cell therapy entrepreneurs and innovators. The series consists of three events during 2026 in Copenhagen:

• Immunotherapy (March 26)
• Stem cell therapy (June 4)
• Cell Therapy Translation and Production (September 24)

We welcome you to the first networking and seminar session on Immunotherapy, March 26 2026.

We have invited Professor Sine Reker Hadrup, head of the Section for Experimental and Translational Immunology at DTU, to present her research on T‑cell immune responses and cancer immunotherapies, including personalized vaccines and engineered T‑cell therapies.

Following her, Assistant Professor Maria Ormhøj from the Section for Biotechnology at SDU will share her work on next‑generation CAR‑T cell therapies. Maria develops strategies to target resistant cancers more precisely and engage the immune system for stronger, longer-lasting effects.

Our final speaker is Fábio Rosa, Head of Research at Swedish biotech start-up Asgard Therapeutics. Dr. Rosa will present the company’s innovative approach to cancer cell reprogramming, turning tumor cells into immune cells to trigger a potent antitumor response. Asgard builds on Dr. Felipe Pereira’s research at Lund University to advance next-generation cancer immunotherapies.

Together, these speakers will highlight cutting-edge research and translational strategies shaping the future of cancer immunotherapy.

After the presentations there will be a Q&A session where you can ask your questions to the experts, followed by a networking session with gourmet finger food.

Agenda:

15:00 - Meet and greet, refreshments and networking

15:30 - Bo Wiinberg, Chief Business Development Officer, Cellerator/Martin Schalén, Biopharma Account Manager Miltenyi Biotec Nordics - Welcome and introduction

15:35 - Sine Reker Hadrup, Professor in Experimental and Translational Immunology, Technical University of Denmark

- Title TBD

15:55 - Maria Ormhøj, Assistant Professor, Section for Biotechnology, Department of Green Technology, University of Southern Denmark (SDU)

- Title TBD

16:15: Fábio Rosa, Head of Research, Asgard Therapeutics

- Using Immune Cell Reprogramming to Reinstate Anti-Cancer Immunity

16.35 - Q&A roundtable discussion

17.00 - Drinks, refreshments, networking etc.

We are looking forward to meet and network together with you!

//Miltenyi Biotec and Cellerator

This is a scientific networking event. We kindly ask additional providers of instrumentation and equipment to not participate in this event as a means to meet potential customers.

We look forward to meet and network with fellow cell therapy scientists!